Contract 75F40119P10437
Sino Biological Us Inc. · Department Of Health And Human Services · August 29, 2019
Sino Biological Us Inc. was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on August 29, 2019 for $23,000 of work in biological product (except diagnostic) manufacturing. Performance is in Chesterbrook, PA. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on April 21, 2022.
Contract details
- PIID
- 75F40119P10437
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
- Place of performance
- Chesterbrook, PA
- First action
- August 29, 2019
- Latest action
- April 21, 2022
Description
MODIFICATION TO INCORPORATE IPP CLAUSE
Modification timeline
-
April 21, 2022Mod P00001$0
-
August 29, 2019Base awardWILD-TYPE AND 6 PURIFIED VARIANTS OF THE CAS9 PROTEIN$23.1K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75F40119P10437?
Contract 75F40119P10437 is a federal contract awarded to Sino Biological Us Inc. by Department Of Health And Human Services on August 29, 2019 for $23,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 75F40119P10437?
Sino Biological Us Inc. won contract 75F40119P10437 from Department Of Health And Human Services.
How much is contract 75F40119P10437 worth?
Contract 75F40119P10437 has obligated $23,000 to date.